Companies/US/SYK

STRYKER CORPORATION

Income flow

Annual
SYK 10-K Income StatementPeriod 2025-12-31Source 10-K
Med Surg And Neurotechnology$11BOrthopaedics And Spine$7BOrthopaedics$7BRevenue$25B+11% Y/YGross profit$16B+11% Y/YCost of revenue$9BOperating profit$5B+33% Y/YOperating expenses$11BNet profit$3B+9% Y/YTax$1BSG&A$9BR&D & other$3B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$34.6B
  • Med Surg And Neurotechnology$15.6B45.2%
  • Orthopaedics And Spine$9.5B27.4%
  • Orthopaedics$9.5B27.4%
By geography
By geography$31.2B
  • United States$19.0B60.9%
  • Non-US$6.1B19.6%
  • EMEA$3.2B10.2%
  • Asia Pacific$2.2B6.9%
  • Other Foreign Countries$765M2.5%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.25%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.0.99%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).3.48PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.36.1%Shares outTotal shares currently outstanding (issued and not retired).383.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).348.1M
Upcoming dividend
Ex-dividend
2026-09-30
Next pay
2026-10-30
Last cash
0.88 · 2026-09-30
Stock splits
  1. 2:12004-05-17

Valuation

Trailing PE 41.5 (2025-12-31)PE trend

Fiscal PE5

PeriodEPSClosePE
2025-12-318.4348.4841.5
2024-12-317.76353.7245.6
2023-12-318.25291.5135.3
2022-12-316.17235.4738.2
2021-12-315.21254.3448.8

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.